Dana-Farber's Rachel Pozzar, PhD, RN, shares research that found 45% of patients with gynecologic cancer reported clinically meaningful levels of anxiety that were associated with a higher symptom burden. She presented at the ONS Congress 2022. Video published, April 2022.